Oxford Biomedical Gets $1.2M Grant To Develop Proteomic Toxicity Screening PanelOxford Biomedical Research Inc., a privately held biotechnology company in Rochester Hills, has been awarded a $1,163,600 Phase 2 Small Business Innovation Research Grant by the National Institute of Environmental Health Sciences.

More From CBS Detroit

Guide: Last Minute Valentine's Day IdeasYou've got less than a week to plan the most romantic night of the year. Better get going!
Best Places To Get A Hot Toddy
Best Sledding Hills

Watch & Listen